Date set for MA Blues' doctors to start e-prescribing; Will FDA fast-track Avastin for brain cancer?;

> Doctors participating in the physician incentives program from Blue Cross Blue Shield of Massachusetts are soon going to have to start e-prescribing to stay in the program. FierceHealthIT
> In an attempt to curb patient ID theft and fraud, a California health system is now using palm vein authentication technology as a part of it's registration system. Article
> Genentech is asking the FDA for yet another approval for the cancer med Avastin, this time as a remedy for the most aggressive form of brain cancer. The company has requested that the FDA fast track the app so that Avastin could obtain provisional approval based on some preliminary data. FiercePharma

And Finally... I wonder if this guy ever tried to rob any lemonade stands as well. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.